Ingevity Corporation (NYSE: NGVT) stock plummeted 5.04% intraday on Thursday, reacting to the company's fourth-quarter and full-year 2024 earnings results and cautious guidance for 2025.
The key negative points from the earnings call that likely impacted the stock price negatively include:
Additionally, the Q&A section highlighted some concerns regarding input costs and potential tariff impacts:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.